NDRA.US ENDRA Life Sciences Inc

Healthcare Health Care Equipment & Supplies USA Stocks
4.41 USD
Close of Nov 15, 2026
2.96 6.80
Market cap
USD 6.61M
P/E
-
P/B
1.05x
ROE
-36.5%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is NDRA.US undervalued?

Graham number

The Graham number of ENDRA Life Sciences Inc cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

ENDRA Life Sciences Inc fundamental analysis

No fundamental analysis for ENDRA Life Sciences Inc yet.

ENDRA Life Sciences Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About ENDRA Life Sciences Inc

ENDRA Life Sciences Inc. develops technologies to improve the capabilities of clinical diagnostic ultrasound. The company is involved in the development of thermo-acoustic enhanced ultrasound technology that uses pulsed energy source such as radio frequency to transmit energy deep into tissue and generate ultrasonic waves to create high-contrast images for use in the treatment of non-alcoholic fatty liver disease, as well as in tissue composition, temperature monitoring, vas…

Full company profile